내용 바로 가기

하위 메뉴 바로 가기

여호와의 증인

한국어

Cardiothoracic and Vascular Surgery

Management and Optimization of Hemostasis

Case 12-2016 ascending aorta dissection in a Jehovah's Witness patient on warfarin.

Silvetti S, Crivellari M, Castiglioni A, Landoni G, Zangrillo A, Alfieri O, Koster A, Faraoni D, Bolliger D, Tanaka KA

Source‎: J Cardiothorac Vasc Anesth 2016;30(6):1709-15.

Indexed‎: PubMed 27639716

DOI‎: 10.1053/j.jvca.2016.02.029

http://www.ncbi.nlm.nih.gov/pubmed/27639716

Alternatives to allogeneic platelet transfusion.

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ

Source‎: Br J Haematol 2016;175(3):381-92.

Indexed‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

http://www.ncbi.nlm.nih.gov/pubmed/27650431

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST).

Ranucci M, Baryshnikova E

Source‎: Br J Anaesth 2016;116(5):618-23.

Indexed‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

http://www.ncbi.nlm.nih.gov/pubmed/26893405

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery.

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM

Source‎: Drugs R D 2015;15(2):187-94.

Indexed‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

http://www.ncbi.nlm.nih.gov/pubmed/25862216

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Source‎: J Am Heart Assoc 2015;4(6):e002066.

Indexed‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

http://www.ncbi.nlm.nih.gov/pubmed/26037084

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Source‎: Anesthesiology 2011;115(6):1179-1191.

Indexed‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

http://www.ncbi.nlm.nih.gov/pubmed/21970887

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Source‎: Anesthesiology 2013;118(1):40-50.

Indexed‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

http://www.ncbi.nlm.nih.gov/pubmed/23249928

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Source‎: Innovations (Phila) 2012;7(4):229-41.

Indexed‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

http://www.ncbi.nlm.nih.gov/pubmed/23123988

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Source‎: Heart Lung Circ 2012;21(11):706-10.

Indexed‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

http://www.ncbi.nlm.nih.gov/pubmed/22842057

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Source‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indexed‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

http://www.ncbi.nlm.nih.gov/pubmed/22233480

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Source‎: Can J Anaesth 2012;59(3):299-303.

Indexed‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

http://www.ncbi.nlm.nih.gov/pubmed/22161243

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Source‎: Anesth Analg 2012;115(2):239-43.

Indexed‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

http://www.ncbi.nlm.nih.gov/pubmed/21737704

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Source‎: J Vasc Surg 2011;53(4):1032-7.

Indexed‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

http://www.ncbi.nlm.nih.gov/pubmed/21215579

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Source‎: Circulation 2009;120(1):21-7.

Indexed‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

http://www.ncbi.nlm.nih.gov/pubmed/19546387


jw.org의 의학 부문은 주로 임상의나 다른 의료 전문가들에게 정보를 제공하기 위해 마련되었습니다. 여기서 제공하는 정보는 의료 상담이나 치료 권고 사항을 담고 있지 않으며, 의료 전문가를 대신하기 위한 목적으로 마련된 것도 아닙니다. 여기 인용된 임상 문헌은 고려할 만한 수혈 대체 치료 방안들을 간략히 보여 주기 위한 것이며, 여호와의 증인이 발행한 것은 아닙니다. 의료 전문가 각자에게는 최신 정보에 계속 관심을 갖고, 사용 가능한 치료 방법을 논의하며, 환자가 본인의 질병, 희망 사항, 가치관, 신념에 맞는 치료 방법을 선택할 수 있도록 도울 책임이 있습니다. 여기에 나오는 모든 치료 방안이 어느 환자에게든 적합하거나 받아들여지는 것은 아닙니다.

환자가 유의할 점: 질병이나 치료와 관련된 문제는 항상 의사나 다른 의료 전문가의 조언을 구하십시오. 아픈 것 같다면 의사와 상담하십시오.

본 웹사이트의 이용은 이 사이트 약관의 제약을 받습니다.